n-Lorem Foundation

About n-Lorem Foundation

N-Lorem Foundation uses antisense technology to create individualized treatments for patients with nano-rare diseases. Antisense medicines, also known as antisense oligonucleotides or ASOs, are intended to precisely connect with RNA, preventing the process of generating a protein that causes sickness. This disrupts the course of diseases, from the most uncommon to those that affect millions of people. For nano-rare patients who are amenable to the company's technology, the n-Lorem Foundation provides the infrastructure, resources, and access necessary for them to receive experimental Antisense oligonucleotides (ASOs) without charge.